Robust TMTT Growth to Drive Edwards Lifesciences' Q2 Earnings

• click to rate

  Posted by Two Blokes Jul 22 - Filed in Stock - 8 views
  
  EW's Q2 earnings report is likely to benefit from soaring TMTT sales, with the segment expected to jump over 57% year over year.